Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer

  • Technology appraisal guidance
  • TA61
  • Published: 
Download guidance (PDF)

Update information

Minor changes since publication

June 2018: The recommendations were updated because tegafur with uracil is no longer available.

March 2014: Implementation section updated to clarify that capecitabine and tegafur with uracil are recommended as options for treating metastatic colorectal cancer. Additional minor maintenance update also carried out.

ISBN: 978-1-4731-3038-8